Trials / Terminated
TerminatedNCT05447910
Analysis of Letrozole in Patients With Operable Hormone Receptor Positive, HER2 Negative Breast Cancer
Comprehensive Single-Cell Transcriptional Analysis of Aromatase Inhibitor-Resistant Breast Cancer
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 21 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to study to collect tissue samples from patients with early stage hormone receptor-positive HER2-negative breast cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Biospecimen Collection | Undergo collection of blood and tissue samples |
Timeline
- Start date
- 2022-07-21
- Primary completion
- 2023-09-27
- Completion
- 2023-09-27
- First posted
- 2022-07-07
- Last updated
- 2025-06-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05447910. Inclusion in this directory is not an endorsement.